APEA- Pharm Cardiovascular Study Review Practice
Test.
1. The side effect profile of angiotensin
angiotensin-converting
receptor blockers (ARBs) is similar to the
enzymes (ACE) inhibitors.
side effects of: angiotensin-converting
enzymes (ACE) in- hibitors.
beta-blockers.
calcium channel blockers.
pressors.
2. Isosorbide dinitrate (Isordil) is indicated for the chronic angina.
treatment of:
acute angina. Isosorbide dinitrate (Isordil)
chronic angina. titradose tablets are indicated
myocardial infarction. for the pre- vention of angina
esophageal spasm. pectoris due to coronary artery
disease. The onset
of action of immediate-release
oral isosorbide dinitrate is not
suflcient- ly rapid for this
product to be useful in aborting
an acute anginal episode.
Therefore, it is not indicated in
the treatment of acute angina
and my- ocardial infarction. The
treatment of esophageal
3. Non-dihydropyridine calcium channel spasms disorders is an ott-
blockers (i.e. verapamil) may be safely label use.
used in patients with:
heart failure. chronic stable angina.
bradycardia.
Non-dihydropyridine CCBs (non-
second-degree AV
DHP CCB; i.e. verapamil [Calan]
block. chronic stable
and dil- tiazem [Cardizem]) have
angina.
, APEA- Pharm Cardiovascular Study Review Practice
Test.
negative chronotropic and inotropic ettects.
Therefore, they slow down heart rate and decrease force of ventricular
con-
, APEA- Pharm Cardiovascular Study Review Practice
Test.
tractions. Non-DHP CCBs are
con- traindicated in patients with
heart fail- ure who have reduced
ejection frac- tion, sick sinus
syndrome, and sec- ond- or
third-degree atrioventricu- lar
block. Since non-DHP CCBs in-
crease myocardial blood flow by
di- lating coronary arteries, they
are ben- eficial in patients with
chronic stable angina.
4. Patients who are started on
olmesartan (Benicar) should be diarrhea and weight loss.
advised to report: bladder
Patients should be advised to
spasms and dysuria. constipation
and weakness.
re-
diarrhea and weight loss.
port persistent chronic diarrhea
metallic taste and easy and
bruising. weight loss while taking
olmesar- tan medoxomil
(Benicar). This drug can produce
a sprue-like enteropa- thy
characterized by severe chronic
diarrhea and weight loss
occurring months to years after
initiation of the drug. Benicar is
an angiotensin re- ceptor
blocker (ARB). Once other eti-
ologies have been excluded,
discon- tinue Benicar and
consider an alter- native
hypertension treatment.
, APEA- Pharm Cardiovascular Study Review Practice
Test.
5. The medication that produces vasodilation and enalapril (Vasotec).
thus lowers blood pressure by inhibiting the
formation of angiotensin Amlodipine (Norvasc) is a
II is: amlodipine calcium channel blocker, losartan
(Norvasc). losartan (Cozaar) is an angiotensin II
(Cozaar). receptor block-
Test.
1. The side effect profile of angiotensin
angiotensin-converting
receptor blockers (ARBs) is similar to the
enzymes (ACE) inhibitors.
side effects of: angiotensin-converting
enzymes (ACE) in- hibitors.
beta-blockers.
calcium channel blockers.
pressors.
2. Isosorbide dinitrate (Isordil) is indicated for the chronic angina.
treatment of:
acute angina. Isosorbide dinitrate (Isordil)
chronic angina. titradose tablets are indicated
myocardial infarction. for the pre- vention of angina
esophageal spasm. pectoris due to coronary artery
disease. The onset
of action of immediate-release
oral isosorbide dinitrate is not
suflcient- ly rapid for this
product to be useful in aborting
an acute anginal episode.
Therefore, it is not indicated in
the treatment of acute angina
and my- ocardial infarction. The
treatment of esophageal
3. Non-dihydropyridine calcium channel spasms disorders is an ott-
blockers (i.e. verapamil) may be safely label use.
used in patients with:
heart failure. chronic stable angina.
bradycardia.
Non-dihydropyridine CCBs (non-
second-degree AV
DHP CCB; i.e. verapamil [Calan]
block. chronic stable
and dil- tiazem [Cardizem]) have
angina.
, APEA- Pharm Cardiovascular Study Review Practice
Test.
negative chronotropic and inotropic ettects.
Therefore, they slow down heart rate and decrease force of ventricular
con-
, APEA- Pharm Cardiovascular Study Review Practice
Test.
tractions. Non-DHP CCBs are
con- traindicated in patients with
heart fail- ure who have reduced
ejection frac- tion, sick sinus
syndrome, and sec- ond- or
third-degree atrioventricu- lar
block. Since non-DHP CCBs in-
crease myocardial blood flow by
di- lating coronary arteries, they
are ben- eficial in patients with
chronic stable angina.
4. Patients who are started on
olmesartan (Benicar) should be diarrhea and weight loss.
advised to report: bladder
Patients should be advised to
spasms and dysuria. constipation
and weakness.
re-
diarrhea and weight loss.
port persistent chronic diarrhea
metallic taste and easy and
bruising. weight loss while taking
olmesar- tan medoxomil
(Benicar). This drug can produce
a sprue-like enteropa- thy
characterized by severe chronic
diarrhea and weight loss
occurring months to years after
initiation of the drug. Benicar is
an angiotensin re- ceptor
blocker (ARB). Once other eti-
ologies have been excluded,
discon- tinue Benicar and
consider an alter- native
hypertension treatment.
, APEA- Pharm Cardiovascular Study Review Practice
Test.
5. The medication that produces vasodilation and enalapril (Vasotec).
thus lowers blood pressure by inhibiting the
formation of angiotensin Amlodipine (Norvasc) is a
II is: amlodipine calcium channel blocker, losartan
(Norvasc). losartan (Cozaar) is an angiotensin II
(Cozaar). receptor block-
